FDA Should Cite Regulatory Imperative When Narrowing 510(k) Claims – Cook
This article was originally published in The Gray Sheet
Executive Summary
FDA should consult with a three-person "supervisory" panel in deciding whether to narrow a proposed indication statement for 510(k) devices, Cook Group, Inc. suggests in March 4 comments to HHS Secretary Thompson's regulatory reform advisory committee